Actively Recruiting

Age: 10Years +
All Genders
NCT06446271

Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)

Led by NHS Greater Glasgow and Clyde · Updated on 2024-07-03

750

Participants Needed

1

Research Sites

142 weeks

Total Duration

On this page

Sponsors

N

NHS Greater Glasgow and Clyde

Lead Sponsor

U

University of Glasgow

Collaborating Sponsor

AI-Summary

What this Trial Is About

Genetic cardiomyopathy is increasingly recognised and can lead to heart failure, arrhythmia and sudden cardiac death. Some gene positive patients have rapidly progressive disease with high rates of heart failure and cardiac transplantation, while others present with SCD. Other gene positive patients will never develop cardiomyopathy. At present, we cannot distinguish between these groups and rely on expensive and labour-intensive surveillance by electrocardiography, echocardiography and sometimes cardiac magnetic resonance imaging. This study will investigate existing and novel biomarkers (including blood, urine electrocardiographic and imaging) at various stages of disease in patients with a personal or family history of TTN, MYBPC3, LMNA, FLNC or DSP gene variant, which are known to cause cardiomyopathy.

CONDITIONS

Official Title

Biomarkers in SCOTland CardiomyopatHy Registry (Bio-SCOTCH)

Who Can Participate

Age: 10Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female 10 years of age or older
  • Written informed consent or assent
  • Pathogenic or likely pathogenic variant in a cardiomyopathy gene (TTN, LMNA, MYBPC3, DSP, FLNC) or undergoing predictive genetic testing (negative results invited to control arm)
Not Eligible

You will not qualify if you...

  • Unable to consent
  • Geographical or social reasons preventing attendance at study center
  • Unable to complete study assessments
  • Severe non-cardiac disease expected to reduce life expectancy to less than 5 years
  • Current participation in a blinded drug interventional trial or treatment within 4 weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Queen Elizabeth University Hospital

Glasgow, United Kingdom, G51 4TF

Actively Recruiting

Loading map...

Research Team

C

Caroline J Coats, MBBS, PhD

CONTACT

R

Rachel C Myles, MBBS, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here